Active vs. Passive VR During Office-based ENT Procedures

Not yet recruitingNot applicableNCT07599826

View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The purpose of this research is to evaluate whether active virtual reality reduces pain and anxiety more effectively than passive virtual reality during office-based ENT procedures. The main procedures include exposure to virtual reality (passive calming scenery or interactive puzzle game) via Paperplane Therapeutics software with VR headset or glasses during common in-office ENT procedures, participant self-report surveys (GAD-7, PHQ-9, PEG, VAS, SUDS, Likert, experience questions), and physician post-procedure survey. The study will enroll individuals 18 years or older who are scheduled to undergo common office-based ENT procedures (turbinate reduction, nasal debridement, balloon sinuplasty, radiofrequency ablation, nasal polypectomy, eustachian tube dilation, vocal fold injection, or subglottic steroid injection) at Cedars-Sinai.

Study details

Official title: Active vs. Passive Virtual Reality for Reducing Pain and Anxiety During Office-based ENT Procedures
Conditions: Pain
Anxiety
Chronic Rhinosinusitis (CRS)
Nasal Obstruction
Nasal Polyp
Eustachian Tube Dysfunction
Dysphonia
Subglottic Stenosis (SGS)
Interventions: Device: Passive virtual reality headset or goggles
Device: Active virtual reality headset or goggles
Sponsor: Cedars-Sinai Medical Center
Start date: 2026-09
Primary completion: 2027-06
Sex: All
Age range: from 18 Years
Results posted: No results posted in this snapshot
Countries: United States
Total sites listed: 1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)

Inclusion Criteria Active and Passive VR: * Individuals 18 years old and older are included * Individuals undergoing the following common office-based ENT procedures: turbinate reduction, nasal debridement, balloon sinuplasty, radiofrequency ablation (RhinAer/VivAer), nasal polypectomy, eustachian tube dilation, vocal fold injection, or subglottic steroid injection * Able to consent * English speaking Exclusion Criteria Active VR: * History of neurologic or seizure disorder, developmental delay, uncorrected visual impairment, motion sickness, vertigo, or inability to use a handheld controller * Any records flagged "break the glass" or "research opt out." Exclusion Criteria Passive VR: * History of neurologic or seizure disorder, developmental delay, uncorrected visual impairment, motion sickness, or vertigo * Any records flagged "break the glass" or "research opt out."

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07599826